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Abstract
Intraindividual variability (IIV) refers to reaction time (RT) variation across the trials of a given cognitive task. Little
research has contrasted different measures of IIV or assessed how many RT trials are required to provide a robust measure
of the construct. We, therefore, investigated three measures of IIV (raw SD, coefficient of variation, and intraindividual
SD statistically removing time-on-task effects) in relation to frontal white matter hyperintensities (obtained through
structural MRI) in 415 cognitively normal community-dwelling adults aged 44 to 48 years. Results indicated the three IIV
measures did not differ greatly in predictions of white matter hyperintensities, although it is possible that time-on-task
effects were influential. As few as 20 trials taking approximately 52 s to administer provided a reliable prediction of
frontal white matter hyperintensities. We conclude that future work should evaluate the comparative utility of different
IIV measures in relation to persons exhibiting clear neuropathology. (JINS, 2013, 19, 971–976)
Keywords: Age, Within-person variability, White matter hyperintensities, Frontal cortex lesions, Neuropsychological
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INTRODUCTION
Intraindividual reaction time (RT) variability refers to the
within-person trial-to-trial response time variability of a given
cognitive task. It is the focus of considerable research interest in
the cognitive and clinical neuropsychology of aging fields as
well as several other areas (e.g., schizophrenia, head injury)
because it may provide a behavioral marker of neurobiological
disturbance (Hultsch, Strauss, Hunter, & MacDonald, 2008;
MacDonald, Nyberg, & Backman, 2006). Consistent with
this proposition, greater intraindividual variability (IIV) is
associated with mild dementia (Bielak, Hultsch, Strauss,
MacDonald, & Hunter, 2010; Cherbuin, Sachdev, & Anstey,
2010; Hultsch, MacDonald, Hunter, Levy-Bencheton, &
Strauss, 2000; Tales et al., 2012), Parkinson’s disease (de Frias,
Dixon, Fisher, & Camicioli, 2007), brain injury (Stuss, Pogue,
Buckle, & Bonder, 1994), mild psychopathology (Bunce,
Handley, & Gaines, 2008), and it also increases in normal
aging (Bielak, Cherbuin, Bunce, & Anstey, 2013; Hultsch,
MacDonald, & Dixon, 2002).
As this brief review shows, measures of IIV have
considerable potential in clinical contexts as they may aid
identification and diagnosis of a range of neurobiological dis-
orders. Additionally, they are quick to administer. However,
although there has been considerable research investigating
IIV, there is little consensus concerning how to measure the
construct. This is evidenced by the literature where several
computations of IIV can be found using varying numbers of
RT trials derived from a wide selection of neuropsychological
tasks. Additionally, the relative merits of the different mea-
sures of IIV have received little attention. Three metrics
are predominant in the literature; the raw intraindividual
SD which does not control for any potential confounding
influences; the coefficient of variation (i.e., intraindividual
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SD/raw intraindividual M) which adjusts IIV by the mean
level of RT performance; and, the intraindividual SD that
statistically partials out influences that may artefactually inflate
IIV such as time-on-task effects (e.g., Hultsch et al., 2002;
additionally, see Hultsch et al., 2008, for a statistical discussion
of each method). Few studies have directly contrasted different
measures of IIV, and those that have suggest that different IIV
metrics produce converging results (e.g., Lovden, Li, Shing, &
Lindenberger, 2007). Research also shows that caution should
be observed when controlling for influences such as mean
RT as the method used can affect IIV associations with, for
example, age (Dykiert, Der, Starr, & Deary, 2012b). Impor-
tantly though, direct comparisons of the raw intraindividual
SD to that adjusted for mean RT indicate that age-related
increases in IIV are not accounted for by mean RT (Dykiert,
Der, Starr, & Deary, 2012a), a finding suggesting that IIV
captures sources of variance other than those attributable to
age-related slowing. This is underlined by studies showing
that relative to mean RT, IIV is particularly sensitive to mild
cognitive impairment (e.g., Dixon et al., 2007) and mild psy-
chopathology (e.g., Bunce et al., 2008).
As there is a need for additional information regarding
the measures used to quantify IIV, in the present study we
compared the three commonly used measures and asked
(1) which measure provides the strongest concurrent predic-
tion of frontal white matter hyperintensities, and (2) how
many RT trials are required to achieve this? To answer these
questions, we used data from a recent study (Bunce et al.,
2010) in a sample of adults aged 44 to 48 years drawn
from the population-based PATH Through Life Study. In
this investigation, we described the association between
within-person variability and left frontal cortex macroscopic
white matter lesions (referred to as white matter hyper-
intensities: WMH) obtained from T1-weighted MRI scans. In
other studies, WMH have been associated with cognitive
decline in non-demented individuals and particularly in
frontal executive function (Jokinen et al., 2011; van der Flier
et al., 2005), a variety of histopathological abnormalities
(Gouw et al., 2011), and future risk of dementia (Debette &
Markus, 2010). These findings suggest WMH have potential
as early markers of cerebral ill-health.
There are several features of our earlier study that make it
well-suited for the present evaluative purposes. First, although
the future clinical status of our participants is currently unclear,
the presence of WMH in this sample of apparently healthy
middle aged adults is a possible early marker of age-related
neuropathology. Second, the narrow age range minimizes the
potential confounding influence of the between-subject factor
age on the degree of within-person variability. Third, the RTs
were drawn from a psychomotor task (choice RT), variations of
which are typically used in aging and clinical neuropsycho-
logical research. Finally, 40 trials were administered, allowing
estimations of the strength of association between WMH and
IIV using varying numbers of RT trials to compute the latter
variable. Although we also found an association between IIV
and temporal WMH in the original investigation (Bunce et al.,
2010), here, we focus on the association between IIV and left
frontal WHM as (a) theoretically, it is proposed that IIV is
related to executive or attentional control (Bunce, MacDonald,
& Hultsch, 2004; Bunce, Warr, & Cochrane, 1993; West,
Murphy, Armilio, Craik, & Stuss, 2002) supported by the
frontal cortex, and (b) there is functional MRI evidence
that IIV is associated with task-related activity in the left
middle prefrontal cortex (Bellgrove, Hester, & Garavan, 2004),
and neuropsychological research showing frontal lesions
are associated with increased IIV (Stuss, Murphy, Binns, &
Alexander, 2003).
METHOD
Participants
Data for the present study were drawn from 2530 persons
aged 44 to 48 years recruited from the electoral roll in Canberra
and surrounding areas in Australia, who were participating in
the PATH Through Life Project, a longitudinal population-
based investigation of age, cognition and mental health (see
Anstey et al., 2012). A randomly selected subsample of 656
persons was offered an MRI scan, 431 of whom eventually
completed. Detailed information on the sample from which the
present subsample was drawn, image analysis and methods,
can be found in the earlier report (Bunce et al., 2010). Here,
415 persons (M age5 46.70; SD5 1.43; 227 women; M years
of education5 14.82; SD5 2.28; non-Caucasian5 16) were
included in the analyses. This figure is slightly lower than in the
earlier investigation which used an imputation procedure to
replace missing data for a minority of cases. Participants with or
without left frontal white matter hyperintensities did not differ
significantly on any of the demographic variables (ps . .55).
All aspects of the project were approved by the Australian
National University Human Research Ethics Committee.
Choice RT Task
As part of a wider neuropsychological battery, forty two-choice
RT trials were administered using a small response box held
with both hands, with left and right buttons at the top that were
depressed using the index fingers. The front of the box had two
red stimulus lights under the left and right buttons respectively
and a green ‘‘get-ready’’ light in the middle beneath these.
Following the ‘‘get-ready’’ light, one of the two red stimulus
lights randomly illuminated to which participants were
instructed to respond as quickly and as accurately as possible
by pressing the corresponding response button. The interval
between the ‘‘get-ready’’ light and the first light of the trial was
2.3 s, but the interval time for the remaining trials varied.
Computation of Intraindividual Variability
Measures
Preprocessing of data for computation of IIV measures
followed procedures commonly used in the literature (e.g.,
Hultsch et al., 2002). Initially, RTs for incorrect trials were
removed together with unusually fast responses (,150 ms)
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and those greater than the individual mean1 3 individual
SDs. The resulting missing values (,6.4%) were replaced
using a regression substitution procedure where individual
regression equations across all valid trials for each participant
were computed to predict and replace the missing values. As
this approach tends to reduce within-person variability, it
represents a conservative approach to the study if IIV.
The raw SD was computed as the standard deviation for
each individual across the trials of the task. Additionally, two
other commonly used measures of IIV were assessed. In the
first, the coefficient of variation (referred to as CV) was
computed as raw intraindividual SD/raw intraindividual
M RT. For the final measure, a regression procedure was used
to compute the intraindividual SDs (referred to as ISD) where
residuals were saved having partialed out categorical trial
effects (i.e., time-on-task effects). The residuals obtained
were then standardized and converted into t scores, and
finally an estimate of each individual’s standard deviation
across the trials was computed. Due to the narrow age range,
neither age nor any other between-subject factor was taken
into account in this residualization procedure. The three
metrics were computed for the first 5, 10, 15, 20, 25, 30, 35,
and 40 trials, resulting in 24 different measures for each
individual (8 raw SDs; 8 CVs; 8 residualized ISDs).
MRI Image Acquisition and Processing
Full details of the imaging protocol and analysis of WMH can
be found elsewhere (Bunce et al., 2010; Wen, Sachdev, Li,
Chen, & Anstey, 2009). Briefly, MRI data were collected using
a 1.5 Tesla Gyroscan scanner (ACS-NT, Philips Medical Sys-
tems, Best, The Netherlands). T1-weighted three-dimensional
(3D) structural MRI images were acquired in coronal plane
using a Fast Field Echo sequence. The fluid-attenuated inver-
sion recovery (FLAIR) sequence used to estimate WMH was
acquired with TR5 11,000 ms, TE5 140 ms, TI5 2,600,
number of excitations5 2, matrix size5 2563 256, and the
field of view was 2303 230 mm. Slice thickness was 4.0 mm
with no gap between slices and in-plane spatial resolution was
0.8983 0.898 mm/pixel. The FLAIR and 3D T1 structural
images of the same subject were co-registered using well-
established procedures (Wen et al., 2009).
RESULTS
Table 1 presents descriptive data for raw SDs, CVs, and ISDs,
and the average time to administer the task for the various
numbers of trials. Consideration of mean scores for raw SD
and CV measures suggests that IIV marginally declines with
increasing numbers of trials. However, for the ISD measure,
which controlled for time-on-task effects, it is noticeable that
following a lower score for the 5-trial measure, values were
relatively stable from 10 trials onward. This may reflect a
practice effect for the opening trials. To assess the number of
trials required to obtain a stable metric relative to the 40 trials
estimate, we conducted a series of t tests that compared the
measure obtained for each number of trials with that for
40 trials. Table 2, which details the paired t tests and corres-
ponding bivariate correlations, shows that for raw SD,
30 trials were required before a nonsignificant result was
obtained in comparison to the 40 trial metric, and for the
CV measure, 35 trials were needed. For the ISD metric,
however, only 10 trials were required before nonsignificant
comparisons were obtained. This finding suggests that
partialing out time on task effects may result in a stable
measure of IIV after fewer trials than for the raw SD and CV
computations. (Bonferroni corrections to the above t tests
only additionally rendered the comparison for raw RT,
10 trials nonsignificant.)
We then formally tested the IIV measures in relation to
WMH. As WMH distributions were bimodal, the variability
measures computed for varying numbers of RT trials were
subjected to logistic regression where left frontal WMH
volumes (present or absent) were regressed onto intracranial
volume and white matter volume at Step 1 (to control for
individual differences in neuroanatomical volumes), and at
Step 2 the respective IIV measures. The model was repeated
for each of the three versions of the IIV measure computed
for the first 5, 10, 15, 20, 25, 30, 35, and 40 RT trials. The
statistic B, together with the associated standard error and
p value obtained from the respective logistic regression
models is reported in Table 3.
With regard to the strength of association between the
respective IIV measures and WMH as indicated by the coef-
ficient B obtained from the logistic regression models, it can be
seen that for all measures, consistently significant predictions
of WMH were obtained from metrics of 20 trials and upward.
The ISD measure that controlled for time-on-task effects
produced the most conservative estimates. As there are several
variables that may influence our findings, we repeated the
logistic regressions adjusting for gender, years of education,
ethnicity, depression, and history of head injuries. The results
from these repeated models did not substantially differ from
the original findings. Additionally, rerunning the models
Table 1. Means (SDs) for IIV measures and administration time as a function of number of trials
Trials 5 10 15 20 25 30 35 40
M Raw SD 59.54 (22.54) 58.24 (20.86) 59.47 (18.97) 58.22 (18.68) 57.82 (18.02) 56.72 (17.21) 55.95 (16.74) 56.27 (19.77)
M CV .20 (.07) .21 (.06) .21 (.05) .20 (.05) .20 (.05) .20 (.05) .19 (.04) .19 (.05)
M ISDa 6.76 (3.15) 7.34 (3.24) 7.64 (2.84) 7.63 (2.80) 7.66 (2.66) 7.67 (2.59) 7.68 (2.51) 7.56 (2.94)
M admin time (s) 12.99 25.97 38.96 51.94 64.93 77.91 90.90 103.88
aT-score metric where the effects of trial are removed.
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adjusting for individual mean RT attenuated some of the
effects for IIV measures, but they all remained significant.
Next, we statistically compared the IIV metrics (raw SD vs.
CV vs. ISD) by (a) repeating the logistic regressions for each
trial number but including all three IIV measures in the
models, and (b) computing the area under the curve (AUC)
for each logistic regression model. The AUC estimates were
then contrasted using the PROC Logistic procedure in SAS
v9.3 (SAS Institute Inc, Cary, NC, 2011) to examine whether
there were differences in accuracy between the respective
measures of IIV in predicting WMH for each number of
trials. Neither procedure revealed any significant differences
among the respective IIV measures (for AUC comparisons,
ps. .34), suggesting the various metrics were similar in
predicting WMH.
Finally, it is worth considering the average time taken to
administer the IIV measures of different trials numbers
(Table 1). For IIV metrics where a significant prediction of
frontal WMH was obtained (20 trials upward), the average
administration time for this CRT task was between 52 and
104 s. Together, these findings suggest that a behavioral
marker of frontal white matter integrity may be obtained in
less than 2 min in clinical settings.
DISCUSSION
To our knowledge, no previous research has compared the
number of trials that contribute to different measures of IIV in
relation to neuroanatomical measures of potential clinical
significance. Particular strengths of the study were that we
investigated a narrow age range (44 to 48 years), thereby
removing a major between-subject influence (i.e., age) that
may confound computations of within-person variability, and
assessed a large community-based sample of 415 persons.
Findings suggested that using more trials to compute IIV
metrics (i.e., 20 to 40 trials) produced stronger predictions
of left frontal WMH. Our findings converged with those
elsewhere (e.g., Lovden et al., 2007) in that there was little
to distinguish the three IIV measures (raw SD, CV, ISD),
although analyses suggested that some of the variation
contributing to predictions may have stemmed from practice
effects and later fatigue inflating the degree of within-person
variability.
WMH reflect cerebrovascular disease and may provide an
early marker of age-related neurological decline. Although the
presence of WMH in this cognitively normal community-based
sample is not necessarily indicative of future neurological
status, our findings demonstrate that measures of IIV
computed from relatively few RT trials are predictive of
white matter integrity. Indeed, IIV measures computed from
as little as 20 trials provided a significant prediction of WMH
burden. As average administration times for the measures
ranged from 51.94 s for 20 trials to 103.88 s for 40 trials, the
potential use of these measures in clinical settings for
assessment purposes is clear, particularly as they are quick to
administer. However, there are several considerations in
reaching this conclusion.
First, in the main, the strength of association grew with the
number of trials administered. As random error reduces as the
number of RT trials increase, the present findings suggest
Table 2. Comparisons of each metric calculated with different numbers of trials with 40 trials
Raw RT CV ISD
r with 40 t with 40 p with 40 r with 40 t with 40 p with 40 r with 40 t with 40 p with 40
5 trials 0.57 3.36 .001 0.47 4.27 .000 0.55 25.68 .000
10 trials 0.71 2.61 .009 0.69 6.65 .000 0.68 21.82 .070
15 trials 0.77 4.97 .000 0.76 8.67 .000 0.74 0.75 .455
20 trials 0.83 3.52 .000 0.81 7.55 .000 0.82 0.86 .390
25 trials 0.86 3.12 .002 0.85 5.01 .000 0.85 1.34 .181
30 trials 0.87 0.95 .342 0.86 3.26 .001 0.87 1.44 .150
35 trials 0.88 20.70 .485 0.87 0.21 .835 0.88 1.70 .090
Note. r with 40: correlation of IIV estimate at n trials with estimate at 40 trials. t with 40: paired t-test comparing IIV estimate at n trials with estimate at
40 trials. p with 40: p-value from paired t-test comparing IIV estimate at n trials with estimate at 40 trials.
Table 3. Logistic regression coefficients B (SE) for WMH regressed on IIV measures as a function of number of trials
Trials 5 10 15 20 25 30 35 40
Raw SD .015 (.008) .014 (.007) .016 (.009) .019 (.009) .023 (.009) .025 (.009) .024 (.010) .019 (.007)
p value .059 .053 .059 .028 .012 .009 .014 .009
CV 5.77 (2.83) 5.73 (2.98) 6.33 (3.34) 6.90 (3.34) 8.64 (3.56) 9.46 (3.66) 9.47 (3.93) 7.95 (3.12)
p value .041 .055 .058 .039 .015 .010 .016 .011
ISD .093 (.052) .089 (.045) .090 (.055) .112 (.054) .137 (.058) .144 (.060) .141 (.063) .119 (.048)
p value .077 .049 .101 .038 .018 .016 .026 .013
Note. The models adjusted for intracranial and white matter volumes.
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caution should be observed in the use of IIV measures
computed from fewer than 20 trials. This is particularly true
in relation to the raw SD and CV measures where, respec-
tively, 30 and 35 trials were needed to obtain a stable estimate
relative to the 40 trial metric. Moreover, it is clear from
consideration of raw and partialed ISDs that some of the
within-person variability in raw SDs that contributed to the
association with WMH may have stemmed from time-on-
task effects as estimates for the ISD measures that controlled
for this influence, were more conservative. By statistically
removing within-person variation related to factors such as
practice and fatigue, it is likely that a closer approximation to
the construct of interest—the IIV associated with macro-
scopic white matter lesions in the left frontal cortex—was
obtained. Additionally, our findings relate to a psychomotor
task, types of which are commonly used in cognitive and
clinical neuropsychological research. It is important that
future research conduct similar analyses in other typically
used cognitive domains such as attention and memory,
as well as systematically varying the number and order of
trials grouped together in randomized experimental designs.
Furthermore, given the potential for clinical screening
demonstrated by numerous other investigations of IIV, an
important next step for research is to develop a normative
database of IIV measures taking into account age, education
and neurological status.
A limitation we should acknowledge, however, is that,
although the present analyses were based on a cognitively
normal sample aged 44 to 48 years and, therefore, minimized
the well-established influence of age on IIV, the findings
may not generalize to older populations or persons suffering
specific neurological disorders. Additionally, we do not know
the future neurological status of those persons exhibiting
WMH in the sample. However, the PATH Through Life study
is a longitudinal investigation and we hope to shed light on
these issues as the research progresses. Also, in the present
study, we evaluated different numbers of trials relative to a
maximum of 40 trials, identifying the minimum number
required for each of the IIV measures to obtain a nonsignificant
comparison. It is possible that had a greater total number of
trials had been administered (e.g., 100), the minimum number
of trials required for a nonsignificant comparison would also
have been greater. Our conclusions, therefore, should be
viewed within the context of the total number of trials admi-
nistered in this study. Finally, in using a succession of logistic
regression models to test the predictive utility of the respective
IIV metrics for different numbers of trials, it is possible that
the findings are subject to Type I error. However, we
have presented the exact p values obtained for each model in
Table 3, and the consistency of the findings lead us to believe
that this is unlikely.
To conclude, although we do not currently know the future
neurological status of our participants, the present findings
suggest that measures of IIV that have taken into account
the influence of time-on-task effects may have potential
in clinical contexts for assessment purposes. Moreover, the
findings suggest that statistically significant predictions can
be obtained from relatively few RT trials administered in as
little as 52 s. Although we do not advocate the use of IIV
measures as a stand-alone screening or diagnostic tool, but
rather as a possible supplement to existing neuropsycho-
logical and biological assessment methods, given the speed of
administration, it is important that future research evaluates
the comparative utility of IIV measures in relation persons
exhibiting clear neuropathology.
ACKNOWLEDGMENTS
David Bunce was supported by a Leverhulme Trust (UK) Research
Fellowship, Kaarin Anstey by National Health and Medical
Research Council (NHMRC) Research Fellowship No. 366756,
Nicolas Cherbuin by NHMRC Early Career Research Fellowship
No. 471501 and Philip Batterham by NHMRC Early Career
Research Fellowship No. 1035262. The research was also supported
by NHMRC of Australia Unit Grant No. 973302, Program Grant
No. 179805, Project grant No. 157125. We thank the study partici-
pants, and also Anthony Jorm, Bryan Rodgers, Helen Christensen,
and PATH interviewers Patricia Jacomb and Karen Maxwell. The
information in this manuscript and the manuscript itself has never
been published either electronically or in print. The authors do not
declare any conflicts of interest.
REFERENCES
Anstey, K.J., Christensen, H., Butterworth, P., Easteal, S.,
Mackinnon, A., Jacomb, T., y Jorm, A.F. (2012). Cohort
profile: The PATH Through Life Project. International Journal of
Epidemiology, 41, 951–960.
Bellgrove, M.A., Hester, R., & Garavan, H. (2004). The functional
neuroanatomical correlates of response variability: Evidence from a
response inhibition task. Neuropsychologia, 42(14), 1910–1916.
Bielak, A.A.M., Cherbuin, N., Bunce, D., & Anstey, K.J. (2013).
Intraindividual variability is a fundamental phenomenon of aging:
Evidence from an 8-year longitudinal study across young, middle,
and older adulthood. Developmental Psychology, [Epub ahead
of print].
Bielak, A.A.M., Hultsch, D.F., Strauss, E., MacDonald, S.W.S., &
Hunter, M.A. (2010). Intraindividual variability in reaction time
predicts cognitive outcomes 5 years later. Neuropsychology, 24,
731–741.
Bunce, D., Anstey, K.J., Cherbuin, N., Burns, R., Christensen, H.,
Wen, W., & Sachdev, P.S. (2010). Cognitive deficits are
associated with frontal and temporal lobe white matter lesions in
middle-aged adults living in the community. PLoS One, 5(10),
e13567, doi:13510.11371/journal.pone.0013567
Bunce, D., Handley, R., & Gaines, S.O., Jr. (2008). Depression,
anxiety, and within-person variability in adults aged 18 to
85 years. Psychology and Aging, 23(4), 848–858.
Bunce, D., MacDonald, S.W.S., & Hultsch, D.F. (2004). Incon-
sistency in serial choice decision and motor reaction times
dissociate in younger and older adults. Brain and Cognition,
56(3), 320–327.
Bunce, D., Warr, P.B., & Cochrane, T. (1993). Blocks in choice
responding as a function of age and physical fitness. Psychology
and Aging, 8(1), 26–33.
Cherbuin, N., Sachdev, P., & Anstey, K.J. (2010). Neuropsycho-
logical predictors of transition from healthy cognitive aging to
RT intraindividual variability 975
mild cognitive impairment: The PATH Through Life Study.
American Journal of Geriatric Psychiatry, 18(8), 723–733.
Debette, S., & Markus, H.S. (2010). The clinical importance of
white matter hyperintensities on brain magnetic resonance
imaging: Systematic review and meta-analysis. British Medical
Journal, 341, c3666. doi:10.1136/bmj.c3666
de Frias, C.M., Dixon, R.A., Fisher, N., & Camicioli, R. (2007).
Intraindividual variability in neurocognitive speed: A comparison
of Parkinson’s disease and normal older adults. Neuropsycho-
logia, 45(11), 2499–2507.
Dixon, R.A., Garrett, D.D., Lentz, T.L., MacDonald, S.W.S.,
Strauss, E., & Hultsch, D.F. (2007). Neurocognitive markers of
cognitive impairment: Exploring the roles of speed and inconsi-
stency. Neuropsychology, 21(3), 381–399. doi:10.1037/0894-
4105.21.3.381
Dykiert, D., Der, G., Starr, J.M., & Deary, I.J. (2012a). Age
differences in intra-individual variability in simple and choice
reaction time: Systematic review and meta-analysis. PLoS One,
7(10), e45759. doi:10.1371/journal.pone.0045759
Dykiert, D., Der, G., Starr, J.M., & Deary, I.J. (2012b). Sex
differences in reaction time mean and intraindividual variability
across the life span. [Research Support, Non-U.S. Gov’t].
Developmental Psychology, 48(5), 1262–1276. doi:10.1037/
a0027550
Gouw, A.A., Seewann, A., van der Flier, W.M., Barkhof, F.,
Rozemuller, A.M., Scheltens, P., & Geurts, J.J. (2011).
Heterogeneity of small vessel disease: A systematic review of
MRI and histopathology correlations. Journal of Neurology,
Neurosurgery, and Psychiatry, 82(2), 126–135. doi:10.1136/
jnnp.2009.204685
Hultsch, D.F., MacDonald, S.W., & Dixon, R.A. (2002). Variability
in reaction time performance of younger and older adults. Journal
of Gerontology B Psychological Sciences, 57(2), P101–P115.
Hultsch, D.F., MacDonald, S.W., Hunter, M.A., Levy-Bencheton,
J., & Strauss, E. (2000). Intraindividual variability in cognitive
performance in older adults: Comparison of adults with mild
dementia, adults with arthritis, and healthy adults. Neuropsychol-
ogy, 14(4), 588–598.
Hultsch, D.F., Strauss, E., Hunter, M.A., & MacDonald, S.W.S. (2008).
Intraindividual variability, cognition and aging. In: F.I.M. Craik, and
T.A. Salthouse (Eds.), The handbook of aging and cognition (3rd ed.,
pp. 491–556). New York: Psychology Press.
Jokinen, H., Gouw, A.A., Madureira, S., Ylikoski, R., van
Straaten, E.C., van der Flier, W.M., y Erkinjuntti, T. (2011).
Incident lacunes influence cognitive decline: The LADIS study.
Neurology, 76(22), 1872–1878. doi:10.1212/WNL.0b013e31821
d752f
Lovden, M., Li, S.C., Shing, Y.L., & Lindenberger, U. (2007).
Within-person trial-to-trial variability precedes and predicts
cognitive decline in old and very old age: Longitudinal data from
the Berlin Aging Study. Neuropsychologia, 45(12), 2827–2838.
MacDonald, S.W., Nyberg, L., & Backman, L. (2006). Intra-
individual variability in behavior: Links to brain structure,
neurotransmission and neuronal activity. Trends in Neuroscience,
29(8), 474–480.
Stuss, D.T., Murphy, K.J., Binns, M.A., & Alexander, M.P.
(2003). Staying on the job: The frontal lobes control individual
performance variability. Brain, 126(Pt 11), 2363–2380.
doi:10.1093/brain/awg237
Stuss, D.T., Pogue, J., Buckle, L., & Bonder, J. (1994).
Characterization of stability of performance in patients with
traumatic brain injury: Variability and consistency on reaction
time tests. Neuropsychology, 8, 316–324.
Tales, A., Leonards, U., Bompas, A., Snowden, R.J., Philips, M.,
Porter, G., & Bayer, A. (2012)y Intra-individual reaction time
variability in amnestic mild cognitive impairment: A precursor to
dementia? Journal of Alzheimer’s Disease, 32, 457–466.
van der Flier, W.M., van Straaten, E.C., Barkhof, F., Verdelho, A.,
Madureira, S., Pantoni, L.,y Scheltens, P. (2005). Small vessel
disease and general cognitive function in nondisabled elderly:
The LADIS study. Stroke, 36(10), 2116–2120. doi:10.1161/
01.STR.0000179092.59909.42
Wen, W., Sachdev, P.S., Li, J.J., Chen, X., & Anstey, K.J. (2009).
White matter hyperintensities in the forties: Their prevalence and
topography in an epidemiological sample aged 44-48. Human
Brain Mapping, 30(4), 1155–1167.
West, R., Murphy, K.J., Armilio, M.L., Craik, F.I., & Stuss, D.T.
(2002). Lapses of intention and performance variability reveal
age-related increases in fluctuations of executive control. Brain
and Cognition, 49(3), 402–419.
976 D. Bunce et al.
